Co-administration of ursodeoxycholic acid with rosuvastatin/ezetimibe in a non-alcoholic fatty liver disease model

BACKGROUND: Ursodeoxycholic acid (UDCA), statins, and ezetimibe (EZE) have demonstrated beneficial effects against non-alcoholic fatty liver disease (NAFLD). We investigated the efficacy of the combination of UDCA and the mix of rosuvastatin (RSV)/EZE in the treatment of NAFLD. METHODS: NAFLD mouse...

Descripción completa

Detalles Bibliográficos
Autores principales: Seo, Sang Hyun, Lee, Da Hyun, Lee, Yu Seol, Cho, Kyung Joo, Park, Hye Jung, Lee, Hye Won, Kim, Beom Kyung, Park, Jun Yong, Kim, Do Young, Ahn, Sang Hoon, Bae, Soo Han, Kim, Seung Up
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379373/
https://www.ncbi.nlm.nih.gov/pubmed/35982712
http://dx.doi.org/10.1093/gastro/goac037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379373/
https://www.ncbi.nlm.nih.gov/pubmed/35982712
http://dx.doi.org/10.1093/gastro/goac037

Ejemplares similares